APA (7th ed.) Citation

Hiroi Eguchi, Toshihiko Kakiuchi, Masanori Nishi, Kanako Kojima-Ishii, Kei Nishiyama, Yuhki Koga, & Muneaki Matsuo. (2022). Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hiroi Eguchi, Toshihiko Kakiuchi, Masanori Nishi, Kanako Kojima-Ishii, Kei Nishiyama, Yuhki Koga, and Muneaki Matsuo. Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Hiroi Eguchi, et al. Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation. Frontiers Media S.A., 2022.